Article Details
Retrieved on: 2024-12-02 19:27:44
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Finally, AQR Capital Management LLC bought a new stake in shares of Outlook Therapeutics during the 2nd quarter worth about $75,000. 11.20% of the ...
Article found on: www.defenseworld.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here